Aller au contenu principal
Profil bibliographique

Jonas Paludo

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
9Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

CAR-T cell therapy researchSingle-cell and spatial transcriptomicsProtein Degradation and InhibitorsIntegrated Circuits and Semiconductor Failure AnalysisLymphoma Diagnosis and Treatment

Les publications récentes

2026 conference-abstract OpenAlex

Abstract 2740: Applications of large language models to CAR-T cell therapy clinical data using Google cloud computing.

Emmanuel Contreras Guzman, Matthew Jankowski, Andre de Menezes Silva Corraes, Malvika Gupta et autres

Abstract Large Language Models (LLM) are being widely adopted into the medical field for their impressive ability to analyze and summarize large amounts of text data. These models enable clinicians and researchers to extract meaningful insights from complex datasets and may assist …

us (code pays fourni par la source)

0 citations Cancer Research
2026 conference-abstract OpenAlex

Abstract 1213: Mitochondrial transcriptome profiles associated with clinical responses to CAR-T therapy in aggressive lymphoma.

Jacqueline A. Turner, Panwen Wang, Patrizia Mondello, Melinda Tan et autres

Abstract Introduction: Therapeutic outcomes in B-cell non-Hodgkin’s lymphoma (B-NHL) have substantially improved with the introduction of chimeric antigen receptor T-cell (CAR-T) therapy. Yet, persistent immune dysfunction and underlying metabolic dysregulation remain major obstacles to achieving durable clinical responses in B-NHL. We hypothesize …

us (code pays fourni par la source)

0 citations Cancer Research
2026 conference-abstract OpenAlex

Abstract 3278: Metabolic pathway signatures defining response to CD19 CAR T-Cell therapy in aggressive B-cell non-hodgkin lymphoma

Melinda S.Y. Tan, Panwen Wang, Patrizia Mondello, Jacqueline A. Turner et autres

Abstract Chimeric antigen receptor (CAR) T-cell therapy achieves high response rates in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma, yet only 40% of patients achieve durable remission. Identifying biological programs linked to long-term response remains critical. As metabolic fitness underlies T-cell persistence and effector …

us (code pays fourni par la source)

0 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.